Global Adalimumab Monoclonal Antibody Biosimilar Supply, Demand and Key Producers, 2023-2029
The global Adalimumab Monoclonal Antibody Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0% CAGR during the forecast period (2023-2029).
The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars provides an alternative option for healthcare providers and payers to choose from, potentially reducing the overall healthcare expenditure associated with biologic treatments.
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
This report studies the global Adalimumab Monoclonal Antibody Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Adalimumab Monoclonal Antibody Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adalimumab Monoclonal Antibody Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Adalimumab Monoclonal Antibody Biosimilar total production and demand, 2018-2029, (K Units)
Global Adalimumab Monoclonal Antibody Biosimilar total production value, 2018-2029, (USD Million)
Global Adalimumab Monoclonal Antibody Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adalimumab Monoclonal Antibody Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Adalimumab Monoclonal Antibody Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Adalimumab Monoclonal Antibody Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Adalimumab Monoclonal Antibody Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adalimumab Monoclonal Antibody Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Adalimumab Monoclonal Antibody Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cadila Healthcare, Torrent Pharmaceuticals, Amgen, Boehringer Ingelheim, Novartis, Samsung Bioepis, Viatris, Pfizer and Fresenius Kabi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adalimumab Monoclonal Antibody Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Adalimumab Monoclonal Antibody Biosimilar Market, By Region:
1. How big is the global Adalimumab Monoclonal Antibody Biosimilar market?
2. What is the demand of the global Adalimumab Monoclonal Antibody Biosimilar market?
3. What is the year over year growth of the global Adalimumab Monoclonal Antibody Biosimilar market?
4. What is the production and production value of the global Adalimumab Monoclonal Antibody Biosimilar market?
5. Who are the key producers in the global Adalimumab Monoclonal Antibody Biosimilar market?
6. What are the growth factors driving the market demand?
The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars provides an alternative option for healthcare providers and payers to choose from, potentially reducing the overall healthcare expenditure associated with biologic treatments.
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
This report studies the global Adalimumab Monoclonal Antibody Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Adalimumab Monoclonal Antibody Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adalimumab Monoclonal Antibody Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Adalimumab Monoclonal Antibody Biosimilar total production and demand, 2018-2029, (K Units)
Global Adalimumab Monoclonal Antibody Biosimilar total production value, 2018-2029, (USD Million)
Global Adalimumab Monoclonal Antibody Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adalimumab Monoclonal Antibody Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Adalimumab Monoclonal Antibody Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Adalimumab Monoclonal Antibody Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Adalimumab Monoclonal Antibody Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adalimumab Monoclonal Antibody Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Adalimumab Monoclonal Antibody Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cadila Healthcare, Torrent Pharmaceuticals, Amgen, Boehringer Ingelheim, Novartis, Samsung Bioepis, Viatris, Pfizer and Fresenius Kabi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adalimumab Monoclonal Antibody Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Adalimumab Monoclonal Antibody Biosimilar Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Syringe
- Pen
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Crohn’s Disease
- Other
- Cadila Healthcare
- Torrent Pharmaceuticals
- Amgen
- Boehringer Ingelheim
- Novartis
- Samsung Bioepis
- Viatris
- Pfizer
- Fresenius Kabi
- Coherus
1. How big is the global Adalimumab Monoclonal Antibody Biosimilar market?
2. What is the demand of the global Adalimumab Monoclonal Antibody Biosimilar market?
3. What is the year over year growth of the global Adalimumab Monoclonal Antibody Biosimilar market?
4. What is the production and production value of the global Adalimumab Monoclonal Antibody Biosimilar market?
5. Who are the key producers in the global Adalimumab Monoclonal Antibody Biosimilar market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Adalimumab Monoclonal Antibody Biosimilar Introduction
1.2 World Adalimumab Monoclonal Antibody Biosimilar Supply & Forecast
1.2.1 World Adalimumab Monoclonal Antibody Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.2.3 World Adalimumab Monoclonal Antibody Biosimilar Pricing Trends (2018-2029)
1.3 World Adalimumab Monoclonal Antibody Biosimilar Production by Region (Based on Production Site)
1.3.1 World Adalimumab Monoclonal Antibody Biosimilar Production Value by Region (2018-2029)
1.3.2 World Adalimumab Monoclonal Antibody Biosimilar Production by Region (2018-2029)
1.3.3 World Adalimumab Monoclonal Antibody Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.5 Europe Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.6 China Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.7 Japan Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adalimumab Monoclonal Antibody Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adalimumab Monoclonal Antibody Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Adalimumab Monoclonal Antibody Biosimilar Demand (2018-2029)
2.2 World Adalimumab Monoclonal Antibody Biosimilar Consumption by Region
2.2.1 World Adalimumab Monoclonal Antibody Biosimilar Consumption by Region (2018-2023)
2.2.2 World Adalimumab Monoclonal Antibody Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.4 China Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.5 Europe Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.6 Japan Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.7 South Korea Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.8 ASEAN Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.9 India Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
3 WORLD ADALIMUMAB MONOCLONAL ANTIBODY BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Adalimumab Monoclonal Antibody Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Adalimumab Monoclonal Antibody Biosimilar Production by Manufacturer (2018-2023)
3.3 World Adalimumab Monoclonal Antibody Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Adalimumab Monoclonal Antibody Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Adalimumab Monoclonal Antibody Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Adalimumab Monoclonal Antibody Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Adalimumab Monoclonal Antibody Biosimilar in 2022
3.6 Adalimumab Monoclonal Antibody Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Adalimumab Monoclonal Antibody Biosimilar Market: Region Footprint
3.6.2 Adalimumab Monoclonal Antibody Biosimilar Market: Company Product Type Footprint
3.6.3 Adalimumab Monoclonal Antibody Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Value Comparison
4.1.1 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Comparison
4.2.1 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Consumption Comparison
4.3.1 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023)
4.5 China Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers and Market Share
4.5.1 China Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023)
4.6 Rest of World Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Adalimumab Monoclonal Antibody Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Syringe
5.2.2 Pen
5.3 Market Segment by Type
5.3.1 World Adalimumab Monoclonal Antibody Biosimilar Production by Type (2018-2029)
5.3.2 World Adalimumab Monoclonal Antibody Biosimilar Production Value by Type (2018-2029)
5.3.3 World Adalimumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Adalimumab Monoclonal Antibody Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Ankylosing Spondylitis
6.2.2 Rheumatoid Arthritis
6.2.3 Crohn’s Disease
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Adalimumab Monoclonal Antibody Biosimilar Production by Application (2018-2029)
6.3.2 World Adalimumab Monoclonal Antibody Biosimilar Production Value by Application (2018-2029)
6.3.3 World Adalimumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cadila Healthcare
7.1.1 Cadila Healthcare Details
7.1.2 Cadila Healthcare Major Business
7.1.3 Cadila Healthcare Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.1.4 Cadila Healthcare Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Cadila Healthcare Recent Developments/Updates
7.1.6 Cadila Healthcare Competitive Strengths & Weaknesses
7.2 Torrent Pharmaceuticals
7.2.1 Torrent Pharmaceuticals Details
7.2.2 Torrent Pharmaceuticals Major Business
7.2.3 Torrent Pharmaceuticals Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.2.4 Torrent Pharmaceuticals Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Torrent Pharmaceuticals Recent Developments/Updates
7.2.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Amgen
7.3.1 Amgen Details
7.3.2 Amgen Major Business
7.3.3 Amgen Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.3.4 Amgen Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Amgen Recent Developments/Updates
7.3.6 Amgen Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Details
7.4.2 Boehringer Ingelheim Major Business
7.4.3 Boehringer Ingelheim Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.4.4 Boehringer Ingelheim Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Boehringer Ingelheim Recent Developments/Updates
7.4.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.5.4 Novartis Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Samsung Bioepis
7.6.1 Samsung Bioepis Details
7.6.2 Samsung Bioepis Major Business
7.6.3 Samsung Bioepis Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.6.4 Samsung Bioepis Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Samsung Bioepis Recent Developments/Updates
7.6.6 Samsung Bioepis Competitive Strengths & Weaknesses
7.7 Viatris
7.7.1 Viatris Details
7.7.2 Viatris Major Business
7.7.3 Viatris Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.7.4 Viatris Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Viatris Recent Developments/Updates
7.7.6 Viatris Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.8.4 Pfizer Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 Fresenius Kabi
7.9.1 Fresenius Kabi Details
7.9.2 Fresenius Kabi Major Business
7.9.3 Fresenius Kabi Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.9.4 Fresenius Kabi Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Fresenius Kabi Recent Developments/Updates
7.9.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.10 Coherus
7.10.1 Coherus Details
7.10.2 Coherus Major Business
7.10.3 Coherus Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.10.4 Coherus Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Coherus Recent Developments/Updates
7.10.6 Coherus Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Adalimumab Monoclonal Antibody Biosimilar Industry Chain
8.2 Adalimumab Monoclonal Antibody Biosimilar Upstream Analysis
8.2.1 Adalimumab Monoclonal Antibody Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Adalimumab Monoclonal Antibody Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Adalimumab Monoclonal Antibody Biosimilar Production Mode
8.6 Adalimumab Monoclonal Antibody Biosimilar Procurement Model
8.7 Adalimumab Monoclonal Antibody Biosimilar Industry Sales Model and Sales Channels
8.7.1 Adalimumab Monoclonal Antibody Biosimilar Sales Model
8.7.2 Adalimumab Monoclonal Antibody Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Adalimumab Monoclonal Antibody Biosimilar Introduction
1.2 World Adalimumab Monoclonal Antibody Biosimilar Supply & Forecast
1.2.1 World Adalimumab Monoclonal Antibody Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.2.3 World Adalimumab Monoclonal Antibody Biosimilar Pricing Trends (2018-2029)
1.3 World Adalimumab Monoclonal Antibody Biosimilar Production by Region (Based on Production Site)
1.3.1 World Adalimumab Monoclonal Antibody Biosimilar Production Value by Region (2018-2029)
1.3.2 World Adalimumab Monoclonal Antibody Biosimilar Production by Region (2018-2029)
1.3.3 World Adalimumab Monoclonal Antibody Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.5 Europe Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.6 China Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.7 Japan Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adalimumab Monoclonal Antibody Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adalimumab Monoclonal Antibody Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Adalimumab Monoclonal Antibody Biosimilar Demand (2018-2029)
2.2 World Adalimumab Monoclonal Antibody Biosimilar Consumption by Region
2.2.1 World Adalimumab Monoclonal Antibody Biosimilar Consumption by Region (2018-2023)
2.2.2 World Adalimumab Monoclonal Antibody Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.4 China Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.5 Europe Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.6 Japan Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.7 South Korea Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.8 ASEAN Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.9 India Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
3 WORLD ADALIMUMAB MONOCLONAL ANTIBODY BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Adalimumab Monoclonal Antibody Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Adalimumab Monoclonal Antibody Biosimilar Production by Manufacturer (2018-2023)
3.3 World Adalimumab Monoclonal Antibody Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Adalimumab Monoclonal Antibody Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Adalimumab Monoclonal Antibody Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Adalimumab Monoclonal Antibody Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Adalimumab Monoclonal Antibody Biosimilar in 2022
3.6 Adalimumab Monoclonal Antibody Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Adalimumab Monoclonal Antibody Biosimilar Market: Region Footprint
3.6.2 Adalimumab Monoclonal Antibody Biosimilar Market: Company Product Type Footprint
3.6.3 Adalimumab Monoclonal Antibody Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Value Comparison
4.1.1 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Comparison
4.2.1 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Consumption Comparison
4.3.1 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Adalimumab Monoclonal Antibody Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023)
4.5 China Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers and Market Share
4.5.1 China Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023)
4.6 Rest of World Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Adalimumab Monoclonal Antibody Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Syringe
5.2.2 Pen
5.3 Market Segment by Type
5.3.1 World Adalimumab Monoclonal Antibody Biosimilar Production by Type (2018-2029)
5.3.2 World Adalimumab Monoclonal Antibody Biosimilar Production Value by Type (2018-2029)
5.3.3 World Adalimumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Adalimumab Monoclonal Antibody Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Ankylosing Spondylitis
6.2.2 Rheumatoid Arthritis
6.2.3 Crohn’s Disease
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Adalimumab Monoclonal Antibody Biosimilar Production by Application (2018-2029)
6.3.2 World Adalimumab Monoclonal Antibody Biosimilar Production Value by Application (2018-2029)
6.3.3 World Adalimumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cadila Healthcare
7.1.1 Cadila Healthcare Details
7.1.2 Cadila Healthcare Major Business
7.1.3 Cadila Healthcare Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.1.4 Cadila Healthcare Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Cadila Healthcare Recent Developments/Updates
7.1.6 Cadila Healthcare Competitive Strengths & Weaknesses
7.2 Torrent Pharmaceuticals
7.2.1 Torrent Pharmaceuticals Details
7.2.2 Torrent Pharmaceuticals Major Business
7.2.3 Torrent Pharmaceuticals Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.2.4 Torrent Pharmaceuticals Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Torrent Pharmaceuticals Recent Developments/Updates
7.2.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Amgen
7.3.1 Amgen Details
7.3.2 Amgen Major Business
7.3.3 Amgen Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.3.4 Amgen Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Amgen Recent Developments/Updates
7.3.6 Amgen Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Details
7.4.2 Boehringer Ingelheim Major Business
7.4.3 Boehringer Ingelheim Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.4.4 Boehringer Ingelheim Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Boehringer Ingelheim Recent Developments/Updates
7.4.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.5.4 Novartis Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Samsung Bioepis
7.6.1 Samsung Bioepis Details
7.6.2 Samsung Bioepis Major Business
7.6.3 Samsung Bioepis Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.6.4 Samsung Bioepis Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Samsung Bioepis Recent Developments/Updates
7.6.6 Samsung Bioepis Competitive Strengths & Weaknesses
7.7 Viatris
7.7.1 Viatris Details
7.7.2 Viatris Major Business
7.7.3 Viatris Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.7.4 Viatris Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Viatris Recent Developments/Updates
7.7.6 Viatris Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.8.4 Pfizer Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 Fresenius Kabi
7.9.1 Fresenius Kabi Details
7.9.2 Fresenius Kabi Major Business
7.9.3 Fresenius Kabi Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.9.4 Fresenius Kabi Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Fresenius Kabi Recent Developments/Updates
7.9.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.10 Coherus
7.10.1 Coherus Details
7.10.2 Coherus Major Business
7.10.3 Coherus Adalimumab Monoclonal Antibody Biosimilar Product and Services
7.10.4 Coherus Adalimumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Coherus Recent Developments/Updates
7.10.6 Coherus Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Adalimumab Monoclonal Antibody Biosimilar Industry Chain
8.2 Adalimumab Monoclonal Antibody Biosimilar Upstream Analysis
8.2.1 Adalimumab Monoclonal Antibody Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Adalimumab Monoclonal Antibody Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Adalimumab Monoclonal Antibody Biosimilar Production Mode
8.6 Adalimumab Monoclonal Antibody Biosimilar Procurement Model
8.7 Adalimumab Monoclonal Antibody Biosimilar Industry Sales Model and Sales Channels
8.7.1 Adalimumab Monoclonal Antibody Biosimilar Sales Model
8.7.2 Adalimumab Monoclonal Antibody Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Adalimumab Monoclonal Antibody Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Adalimumab Monoclonal Antibody Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Adalimumab Monoclonal Antibody Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Adalimumab Monoclonal Antibody Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Adalimumab Monoclonal Antibody Biosimilar Major Market Trends
Table 13. World Adalimumab Monoclonal Antibody Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Adalimumab Monoclonal Antibody Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Adalimumab Monoclonal Antibody Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Adalimumab Monoclonal Antibody Biosimilar Producers in 2022
Table 18. World Adalimumab Monoclonal Antibody Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Adalimumab Monoclonal Antibody Biosimilar Producers in 2022
Table 20. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Adalimumab Monoclonal Antibody Biosimilar Company Evaluation Quadrant
Table 22. World Adalimumab Monoclonal Antibody Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Adalimumab Monoclonal Antibody Biosimilar Production Site of Key Manufacturer
Table 24. Adalimumab Monoclonal Antibody Biosimilar Market: Company Product Type Footprint
Table 25. Adalimumab Monoclonal Antibody Biosimilar Market: Company Product Application Footprint
Table 26. Adalimumab Monoclonal Antibody Biosimilar Competitive Factors
Table 27. Adalimumab Monoclonal Antibody Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Adalimumab Monoclonal Antibody Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Adalimumab Monoclonal Antibody Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Adalimumab Monoclonal Antibody Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Adalimumab Monoclonal Antibody Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 37. China Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 47. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Adalimumab Monoclonal Antibody Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Adalimumab Monoclonal Antibody Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Adalimumab Monoclonal Antibody Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Adalimumab Monoclonal Antibody Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 62. Cadila Healthcare Major Business
Table 63. Cadila Healthcare Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 64. Cadila Healthcare Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Cadila Healthcare Recent Developments/Updates
Table 66. Cadila Healthcare Competitive Strengths & Weaknesses
Table 67. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Torrent Pharmaceuticals Major Business
Table 69. Torrent Pharmaceuticals Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 70. Torrent Pharmaceuticals Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Torrent Pharmaceuticals Recent Developments/Updates
Table 72. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Amgen Basic Information, Manufacturing Base and Competitors
Table 74. Amgen Major Business
Table 75. Amgen Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 76. Amgen Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Amgen Recent Developments/Updates
Table 78. Amgen Competitive Strengths & Weaknesses
Table 79. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim Major Business
Table 81. Boehringer Ingelheim Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 82. Boehringer Ingelheim Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Boehringer Ingelheim Recent Developments/Updates
Table 84. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 88. Novartis Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 92. Samsung Bioepis Major Business
Table 93. Samsung Bioepis Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 94. Samsung Bioepis Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Samsung Bioepis Recent Developments/Updates
Table 96. Samsung Bioepis Competitive Strengths & Weaknesses
Table 97. Viatris Basic Information, Manufacturing Base and Competitors
Table 98. Viatris Major Business
Table 99. Viatris Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 100. Viatris Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Viatris Recent Developments/Updates
Table 102. Viatris Competitive Strengths & Weaknesses
Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Major Business
Table 105. Pfizer Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 106. Pfizer Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pfizer Recent Developments/Updates
Table 108. Pfizer Competitive Strengths & Weaknesses
Table 109. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 110. Fresenius Kabi Major Business
Table 111. Fresenius Kabi Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 112. Fresenius Kabi Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Fresenius Kabi Recent Developments/Updates
Table 114. Coherus Basic Information, Manufacturing Base and Competitors
Table 115. Coherus Major Business
Table 116. Coherus Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 117. Coherus Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Adalimumab Monoclonal Antibody Biosimilar Upstream (Raw Materials)
Table 119. Adalimumab Monoclonal Antibody Biosimilar Typical Customers
Table 120. Adalimumab Monoclonal Antibody Biosimilar Typical Distributors
Table 1. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Adalimumab Monoclonal Antibody Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Adalimumab Monoclonal Antibody Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Adalimumab Monoclonal Antibody Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Adalimumab Monoclonal Antibody Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Adalimumab Monoclonal Antibody Biosimilar Major Market Trends
Table 13. World Adalimumab Monoclonal Antibody Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Adalimumab Monoclonal Antibody Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Adalimumab Monoclonal Antibody Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Adalimumab Monoclonal Antibody Biosimilar Producers in 2022
Table 18. World Adalimumab Monoclonal Antibody Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Adalimumab Monoclonal Antibody Biosimilar Producers in 2022
Table 20. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Adalimumab Monoclonal Antibody Biosimilar Company Evaluation Quadrant
Table 22. World Adalimumab Monoclonal Antibody Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Adalimumab Monoclonal Antibody Biosimilar Production Site of Key Manufacturer
Table 24. Adalimumab Monoclonal Antibody Biosimilar Market: Company Product Type Footprint
Table 25. Adalimumab Monoclonal Antibody Biosimilar Market: Company Product Application Footprint
Table 26. Adalimumab Monoclonal Antibody Biosimilar Competitive Factors
Table 27. Adalimumab Monoclonal Antibody Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Adalimumab Monoclonal Antibody Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Adalimumab Monoclonal Antibody Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Adalimumab Monoclonal Antibody Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Adalimumab Monoclonal Antibody Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 37. China Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Adalimumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 47. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Adalimumab Monoclonal Antibody Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Adalimumab Monoclonal Antibody Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Adalimumab Monoclonal Antibody Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Adalimumab Monoclonal Antibody Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 62. Cadila Healthcare Major Business
Table 63. Cadila Healthcare Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 64. Cadila Healthcare Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Cadila Healthcare Recent Developments/Updates
Table 66. Cadila Healthcare Competitive Strengths & Weaknesses
Table 67. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Torrent Pharmaceuticals Major Business
Table 69. Torrent Pharmaceuticals Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 70. Torrent Pharmaceuticals Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Torrent Pharmaceuticals Recent Developments/Updates
Table 72. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Amgen Basic Information, Manufacturing Base and Competitors
Table 74. Amgen Major Business
Table 75. Amgen Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 76. Amgen Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Amgen Recent Developments/Updates
Table 78. Amgen Competitive Strengths & Weaknesses
Table 79. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim Major Business
Table 81. Boehringer Ingelheim Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 82. Boehringer Ingelheim Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Boehringer Ingelheim Recent Developments/Updates
Table 84. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 88. Novartis Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 92. Samsung Bioepis Major Business
Table 93. Samsung Bioepis Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 94. Samsung Bioepis Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Samsung Bioepis Recent Developments/Updates
Table 96. Samsung Bioepis Competitive Strengths & Weaknesses
Table 97. Viatris Basic Information, Manufacturing Base and Competitors
Table 98. Viatris Major Business
Table 99. Viatris Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 100. Viatris Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Viatris Recent Developments/Updates
Table 102. Viatris Competitive Strengths & Weaknesses
Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Major Business
Table 105. Pfizer Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 106. Pfizer Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pfizer Recent Developments/Updates
Table 108. Pfizer Competitive Strengths & Weaknesses
Table 109. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 110. Fresenius Kabi Major Business
Table 111. Fresenius Kabi Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 112. Fresenius Kabi Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Fresenius Kabi Recent Developments/Updates
Table 114. Coherus Basic Information, Manufacturing Base and Competitors
Table 115. Coherus Major Business
Table 116. Coherus Adalimumab Monoclonal Antibody Biosimilar Product and Services
Table 117. Coherus Adalimumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Adalimumab Monoclonal Antibody Biosimilar Upstream (Raw Materials)
Table 119. Adalimumab Monoclonal Antibody Biosimilar Typical Customers
Table 120. Adalimumab Monoclonal Antibody Biosimilar Typical Distributors
LIST OF FIGURES
Figure 1. Adalimumab Monoclonal Antibody Biosimilar Picture
Figure 2. World Adalimumab Monoclonal Antibody Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adalimumab Monoclonal Antibody Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Adalimumab Monoclonal Antibody Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Adalimumab Monoclonal Antibody Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 12. Adalimumab Monoclonal Antibody Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Adalimumab Monoclonal Antibody Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Adalimumab Monoclonal Antibody Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Adalimumab Monoclonal Antibody Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Adalimumab Monoclonal Antibody Biosimilar Markets in 2022
Figure 26. United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Adalimumab Monoclonal Antibody Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 32. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Type in 2022
Figure 34. Syringe
Figure 35. Pen
Figure 36. World Adalimumab Monoclonal Antibody Biosimilar Production Market Share by Type (2018-2029)
Figure 37. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Type (2018-2029)
Figure 38. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Application in 2022
Figure 41. Ankylosing Spondylitis
Figure 42. Rheumatoid Arthritis
Figure 43. Crohn’s Disease
Figure 44. Other
Figure 45. World Adalimumab Monoclonal Antibody Biosimilar Production Market Share by Application (2018-2029)
Figure 46. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Application (2018-2029)
Figure 47. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Adalimumab Monoclonal Antibody Biosimilar Industry Chain
Figure 49. Adalimumab Monoclonal Antibody Biosimilar Procurement Model
Figure 50. Adalimumab Monoclonal Antibody Biosimilar Sales Model
Figure 51. Adalimumab Monoclonal Antibody Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Adalimumab Monoclonal Antibody Biosimilar Picture
Figure 2. World Adalimumab Monoclonal Antibody Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adalimumab Monoclonal Antibody Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Adalimumab Monoclonal Antibody Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Adalimumab Monoclonal Antibody Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Adalimumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 12. Adalimumab Monoclonal Antibody Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Adalimumab Monoclonal Antibody Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Adalimumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Adalimumab Monoclonal Antibody Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Adalimumab Monoclonal Antibody Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Adalimumab Monoclonal Antibody Biosimilar Markets in 2022
Figure 26. United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Adalimumab Monoclonal Antibody Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Adalimumab Monoclonal Antibody Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Adalimumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 32. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Type in 2022
Figure 34. Syringe
Figure 35. Pen
Figure 36. World Adalimumab Monoclonal Antibody Biosimilar Production Market Share by Type (2018-2029)
Figure 37. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Type (2018-2029)
Figure 38. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Adalimumab Monoclonal Antibody Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Application in 2022
Figure 41. Ankylosing Spondylitis
Figure 42. Rheumatoid Arthritis
Figure 43. Crohn’s Disease
Figure 44. Other
Figure 45. World Adalimumab Monoclonal Antibody Biosimilar Production Market Share by Application (2018-2029)
Figure 46. World Adalimumab Monoclonal Antibody Biosimilar Production Value Market Share by Application (2018-2029)
Figure 47. World Adalimumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Adalimumab Monoclonal Antibody Biosimilar Industry Chain
Figure 49. Adalimumab Monoclonal Antibody Biosimilar Procurement Model
Figure 50. Adalimumab Monoclonal Antibody Biosimilar Sales Model
Figure 51. Adalimumab Monoclonal Antibody Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
